| Patients characteristics |
No. |
% |
Age
< or equal 56 years
>56 years |
44-76 with median 56 y- mean 57.9 ± 7.8 |
| 86
53 |
61,9
38.1 |
Sex
Male
Female |
119
20 |
85.6
14.4 |
Alpha fetoprotein
<20
20-400
>400 |
10
27
102 |
7.2
19.4
73.4 |
Cirrhosis
Present
Absent |
87
52 |
62.6
37.4 |
Viral hepatitis
Present
Absent |
88
51 |
63.3
36.7 |
BCLC
A1
A2
A3
A4
B
C
D |
28
31
24
14
6
20
16 |
20.1
22.3
17.3
10.1
4.3
14.4
11.5 |
Portal vein thrombosis
Yes
No |
76
63 |
54.7
45.3 |
Serum bilirubin
<1.1
>1.1 |
59
80 |
42.4
57.6 |
ALP
20-140IU/l
>140 IU/L |
47
92 |
33.8
66.2 |
AST
≤38
>38 |
23
116 |
16.5
83.5 |
ALT
≤38
>38 |
24
115 |
17.3
82.7 |
Albumin level
3.5-5.5g/L
<3.5gm/L |
52
87 |
37.4
62.6 |
Prothrombin time(PT)
9.5-13.5 sec
>13.5 sec |
82
57 |
59
41 |
Number of tumors
Single
Multiple |
53
86 |
38.1
69.1 |
Size of tumor
<5 cm
5 cm-less than 50%
More than 50% |
37
60
42 |
26.6
43.2
30.2 |
Hepatic metastases
No
Yes |
119
20 |
86.3
17.3 |
Serum p53
Negative
Positive |
122
17 |
87.8
12.2 |
Treatment
surgical resection
radiofrequency
TACE
Chemotherapy
No treatment |
11
18
34
5
71 |
7.9
12.9
24.5
3.6
51.1 |
